| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1365865 | Bioorganic & Medicinal Chemistry Letters | 2007 | 5 Pages |
To address the absence of experimental data on the full-length structure of HIV-1 integrase and the way it binds to viral and human DNA, we had previously [Karki, R. G.; Tang, Y.; Burke, T. R., Jr.; Nicklaus, M. C. J. Comput. Aided Mol. Des.2004, 18, 739] constructed models of full-length HIV-1 integrase complexed with models of viral and human DNA. Here we describe the discovery of novel HIV-1 integrase strand transfer inhibitors based on one of these models. Virtual screening methods including docking and filtering by predicted ADME/Tox properties yielded several μM level inhibitors of the strand transfer reaction catalyzed by wild-type HIV-1 integrase.
Graphical abstractVirtual screening was performed on a model of full-length HIV-1 integrase complexed with viral DNA. Docking into the active site of this model yielded several μM level, structurally novel inhibitors of the strand transfer reaction catalyzed by wild-type HIV-1 integrase.Figure optionsDownload full-size imageDownload as PowerPoint slide
